Writing health technology assessment (HTA) submissions is a challenging and rewarding area of medical writing, being part of the process of giving patients access to new medicines. Submission requirements differ between countries but all require clear communication of the new product’s value. This article looks at the medical writer’s role in UK and German submissions, but many of the points covered will be generalisable to other jurisdictions.